Immunization with FSHβ fusion protein antigen prevents bone loss in a rat ovariectomy-induced osteoporosis model

Biochemical and Biophysical Research Communications

Volumn 434, Issue 2, 2013, Pages 280-286

  Geng, Wenxin ^a   Yan, Xingrong ^a   Du, Huicong ^a   Cui, Jihong ^a   Li, Liwen ^a   Chen, Fulin ^a  

^a NORTHWEST UNIVERSITY   (China)

Author keywords

Follicle stimulating hormone; Ovariectomy; Postmenopausal osteoporosis; Vaccine

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; HYBRID PROTEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; POLYCLONAL ANTISERUM; RECOMBINANT FOLLITROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BODY WEIGHT; BONE MASS; BONE STRENGTH; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IN VITRO STUDY; MENOPAUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; TRABECULAR BONE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; BIOMECHANICS; BONE DENSITY; BONE MARROW; BONE RESORPTION; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; FEMALE; FEMUR; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; IMMUNIZATION; NEUTRALIZATION TESTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS;

ANIMALIA; MUS; RATTUS;

EID: 84877023908     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.116     Document Type: Article

References (33)

1. Lindsay R. Hormones and bone health in postmenopausal women. Endocrine 2004, 24:223-230.
2. Eriksen E.F. Hormone replacement therapy or SERMS in the long term treatment of osteoporosis. Minerva Ginecol. 2012, 64:207-221.
3. Lindberg M.K., Alatalo S.L., Halleen J.M., Mohan S., Gustafsson J.A., Ohlsson C. Estrogen receptor specificity in the regulation of the skeleton in female mice. J. Endocrinol. 2001, 171:229-236.
4. McCauley L.K., Tozum T.F., Rosol T.J. Estrogen receptors in skeletal metabolism: lessons from genetically modified models of receptor function. Crit. Rev. Eukaryot. Gene Expr. 2002, 12:89-100.
5. Windahl S.H., Andersson G., Gustafsson J.A. Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol. Metab. 2002, 13:195-200.
6. Charlesworth M.C., Schwartz N.B. Estrogen inhibition of LH and FSH secretion: effects of a GnRH antagonist. Am. J. Physiol. 1986, 250:E341-345.
7. Piva F., Zanisi M., Martini L. Feedback effect of estrogen on FSH secretion. Experientia 1971, 27:337-338.
8. Yeh J.K., Chen M.M., Aloia J.F. Ovariectomy-induced high turnover in cortical bone is dependent on pituitary hormone in rats. Bone 1996, 18:443-450.
9. Yeh J.K., Chen M.M., Aloia J.F. Effects of 17 beta-estradiol administration on cortical and cancellous bone of ovariectomized rats with and without hypophysectomy. Bone 1997, 20:413-420.
10. Cannon J.G., Kraj B., Sloan G. Follicle-stimulating hormone promotes RANK expression on human monocytes. Cytokine 2011, 53:141-144.
11. Sun L., Zhang Z., Zhu L.L., Peng Y., Liu X., Li J., Agrawal M., Robinson L.J., Iqbal J., Blair H.C., Zaidi M. Further evidence for direct pro-resorptive actions of FSH. Biochem. Biophys. Res. Commun. 2010, 394:6-11.
12. Wu Y., Torchia J., Yao W., Lane N.E., Lanier L.L., Nakamura M.C., Humphrey M.B. Bone microenvironment specific roles of ITAM adapter signaling during bone remodeling induced by acute estrogen-deficiency. PLoS ONE 2007, 2:e586.
13. Zhu L.L., Tourkova I., Yuen T., Robinson L.J., Bian Z., Zaidi M., Blair H.C. Blocking FSH action attenuates osteoclastogenesis. Biochem. Biophys. Res. Commun. 2012, 422:54-58.
14. Liu S., Cheng Y., Fan M., Chen D., Bian Z. FSH aggravates periodontitis-related bone loss in ovariectomized rats. J. Dent. Res. 2010, 89:366-371.
15. Sun L., Peng Y., Sharrow A.C., Iqbal J., Zhang Z., Papachristou D.J., Zaidi S., Zhu L.L., Yaroslavskiy B.B., Zhou H., Zallone A., Sairam M.R., Kumar T.R., Bo W., Braun J., Cardoso-Landa L., Schaffler M.B., Moonga B.S., Blair H.C., Zaidi M. FSH directly regulates bone mass. Cell 2006, 125:247-260.
16. Robinson L.J., Tourkova I., Wang Y., Sharrow A.C., Landau M.S., Yaroslavskiy B.B., Sun L., Zaidi M., Blair H.C. FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. Biochem. Biophys. Res. Commun. 2010, 394:12-17.
17. Lin F., Ren X., Guo H., Ding Q., Zheng A.C. Expression, purification of the UL3 protein of herpes simplex virus type 1, and production of UL3 polyclonal antibody. J. Virol. Methods 2010, 166:72-76.
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
19. Cui Y., Niziolek P.J., MacDonald B.T., Zylstra C.R., Alenina N., Robinson D.R., Zhong Z., Matthes S., Jacobsen C.M., Conlon R.A., Brommage R., Liu Q., Mseeh F., Powell D.R., Yang Q.M., Zambrowicz B., Gerrits H., Gossen J.A., He X., Bader M., Williams B.O., Warman M.L., Robling A.G. Lrp5 functions in bone to regulate bone mass. Nat. Med. 2011, 17:684-691.
20. Wu X.B., Li Y., Schneider A., Yu W., Rajendren G., Iqbal J., Yamamoto M., Alam M., Brunet L.J., Blair H.C., Zaidi M., Abe E. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J. Clin. Invest. 2003, 112:924-934.
21. Abe E., Yamamoto M., Taguchi Y., Lecka-Czernik B., O'Brien C.A., Economides A.N., Stahl N., Jilka R.L., Manolagas S.C. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice. antagonism by noggin. J. Bone Miner. Res. 2000, 15:663-673.
22. Gomori G. Microtechnical demonstration of alkaline phosphatase in tissue sections. Proc. Soc. Exp. Biol. Med. 1939, 42:23.
23. Zhang W., Ma D., Zhao Q., Ishida T. The effect of the major components of Fructus Cnidii on osteoblasts in vitro. J. Acupunct. Meridian Stud. 2010, 3:32-37.
24. Neerup T.S., Stahlhut M., Petersen J.S., Daugaard J.R., Jensen J.E., Peng Z., Morko J., Thorkildsen C. ZP2307, a novel, cyclic PTH(1-17) analog that augments bone mass in ovariectomized rats. Bone 2011, 48:1319-1327.
25. Zhao X., Wu Z.X., Zhang Y., Yan Y.B., He Q., Cao P.C., Lei W. Anti-osteoporosis activity of Cibotium barometz extract on ovariectomy-induced bone loss in rats. J. Ethnopharmacol. 2011, 137:1083-1088.
26. Anumula S., Wehrli S.L., Magland J., Wright A.C., Wehrli F.W. Ultra-short echo-time MRI detects changes in bone mineralization and water content in OVX rat bone in response to alendronate treatment. Bone 2010, 46:1391-1399.
27. Zhang R., Liu Z.G., Li C., Hu S.J., Liu L., Wang J.P., Mei Q.B. Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats. Bone 2009, 45:553-559.
28. Cheng Z., Yao W., Zimmermann E.A., Busse C., Ritchie R.O., Lane N.E. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats. J. Bone Miner. Res. 2009, 24:209-220.
29. Iqbal J., Sun L., Kumar T.R., Blair H.C., Zaidi M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl. Acad. Sci. USA 2006, 103:14925-14930.
30. Leitner W.W., Hwang L.N. M.J. deVeer, A. Zhou, R.H. Silverman, B.R. Williams, T.W. Dubensky, H. Ying, N.P. Restifo, Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat. Med. 2003, 9:33-39.
31. Hernandez J., Garcia-Pons F., Lone Y.C., Firat H., Schmidt J.D., Langlade-Demoyen P., Zanetti M. Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells. Proc. Natl. Acad. Sci. USA 2002, 99:12275-12280.
32. Li X., Ominsky M.S., Warmington K.S., Morony S., Gong J., Cao J., Gao Y., Shalhoub V., Tipton B., Haldankar R., Chen Q., Winters A., Boone T., Geng Z., Niu Q.T., Ke H.Z., Kostenuik P.J., Simonet W.S., Lacey D.L., Paszty C. Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis. J. Bone Miner. Res. 2009, 24:578-588.
33. Shahnazari M., Yao W., Wang B., Panganiban B., Ritchie R.O., Hagar Y., Lane N.E. Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents. J. Bone Miner. Res. 2011, 26:569-581.